Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ultragenyx Pharmaceutical (RARE) Return on Assets (2016 - 2025)

Ultragenyx Pharmaceutical (RARE) has disclosed Return on Assets for 10 consecutive years, with 0.42% as the latest value for Q4 2025.

  • Quarterly Return on Assets fell 41.0% to 0.42% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.42% through Dec 2025, down 41.0% year-over-year, with the annual reading at 0.37% for FY2025, 37.0% down from the prior year.
  • Return on Assets for Q4 2025 was 0.42% at Ultragenyx Pharmaceutical, down from 0.01% in the prior quarter.
  • The five-year high for Return on Assets was 0.03% in Q3 2024, with the low at 0.54% in Q2 2023.
  • Average Return on Assets over 5 years is 0.22%, with a median of 0.23% recorded in 2021.
  • The sharpest move saw Return on Assets skyrocketed 55bps in 2024, then plummeted -41bps in 2025.
  • Over 5 years, Return on Assets stood at 0.3% in 2021, then crashed by -48bps to 0.45% in 2022, then soared by 100bps to 0.0% in 2023, then plummeted by -414bps to 0.0% in 2024, then crashed by -8981bps to 0.42% in 2025.
  • According to Business Quant data, Return on Assets over the past three periods came in at 0.42%, 0.01%, and 0.02% for Q4 2025, Q3 2025, and Q2 2025 respectively.